Home
Fairmount Healthcare Fund II, Director: Viridian Therapeutics, Inc.\DE VRDN Buy · Filed 05/13
Trade details
- Type
- Insider buy
- Amount
- $19,999,990
- Shares · price
- 1,176,470 sh · $17.00 a share
- Held after
- 5,090,928 sh
- Trade date
- 26/05/11
- Filed
- 26/05/13
- Days to filing
- 2 days
First buy since 2023
- Insiders buying this week
- 3 insiders
- Holding change
- +30.1%
Viridian Therapeutics, Inc.\DE trades, last 26 weeks
What else happened in Viridian Therapeutics, Inc.\DE around then
Filed or reported within 30 days of the trade day · 04/11~06/10Fairmount Healthcare Fund II's recent trades
- Fairmount Healthcare Fund II
SellSpyre Therapeutics
SellSpyre Therapeutics
SYRE
$399.7M
4,684,781 sh
$399.7M
Filed 06/23
Traded 06/23
- Fairmount Healthcare Fund II
BuyZenas BioPharma
BuyZenas BioPharma
ZBIO
$3M
150,000 sh
$3M
Filed 04/01
Traded 03/31
- Fairmount Healthcare Fund II
SellApogee Therapeutics
SellApogee Therapeutics
APGE
$133.5M
1,750,000 sh
$133.5M
Filed 01/22
Traded 01/22
- Fairmount Healthcare Fund II
BuyCrescent Biopharma
BuyCrescent Biopharma
CBIO
$18.2M
1,360,000 sh
$18.2M
Filed 25/12/08
Traded 25/12/04
- Fairmount Healthcare Fund II
BuyViridian Therapeutics, Inc.\DE
BuyViridian Therapeutics, Inc.\DE
VRDN
$10M
454,545 sh
$10M
Filed 25/10/27
Traded 25/10/23
